← Insider buys
NKTR

Nektar Therapeutics · Healthcare

Director Christopher A Kuebler sold $1.8M of Nektar Therapeutics

Sold$1,759,800
$58.66Price
30,000Shares
−43%Stake

What NKTR did after the filing

Prices for NKTR after this filing aren't in yet.

Traded Tue, Jan 2. Filed Thu, Jan 4, 1:01 PM ET, during the session. Not investment advice.